Facey, Karen M. http://orcid.org/0000-0001-6670-5271
Bedlington, Nicola
Berglas, Sarah
Bertelsen, Neil
Single, Ann N. V.
Thomas, Victoria
Article History
First Online: 27 July 2018
Compliance with ethical standards
:
: No funding was received for the preparation of this paper.
: Karen Facey was paid an honorarium by Springer to be lead editor of the book on Patient Involvement in HTA. She has received fees from Novartis, UCB, Takeda, the International Plasma Protein Congress, Healthcare Improvement Scotland and the Active Citizens Network since January 2017 for work related to patient involvement in HTA. She has also received expenses from Eurordis and the International Society for Health Economics and Research (ISPOR) to attend meetings related to patient involvement in HTA. Nicola Bedlington’s organization, the European Patients Forum, receives grants from different corporate entities, as listed in annual reports (ExternalRef removed), in accordance with the European Patients’ Forum Framework for Cooperation (ExternalRef removed). Sarah Berglas is employed as a patient engagement officer at CADTH, a Canadian health technology assessment agency. Neil Bertelsen has been paid honoraria and consulting fees as part of his work as a consultant specializing in market access advice and patient involvement in healthcare decision making. These honoraria come from a mix of pharmaceutical industry and patient group sources. Ann Single was paid an honorarium by Springer to be co-editor of the book on Patient Involvement in HTA. She has a voluntary position with the Patient Voice Initiative in Australia. Victoria Thomas is a full-time employee of the National Institute for Health and Care Excellence (NICE), an HTA body.